Patients with indolent systemic<unk>  have a normal life expectancy. The prognosis for patients with advanced systemic<unk>  differs depending on type of disease with MCL being the most serious form with short survival.
Mastocytosis
Monocytosis
Plasmacytosis
Lymphocytosis
Neutropenia
Macrocytosis
Neuroacanthocytosis
Neutrophilia